These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15621884

  • 1. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R, Jackson T, Goodwyn E.
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [Abstract] [Full Text] [Related]

  • 2. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
    Colella R, Goodwyn E, Gopal P.
    Cancer Lett; 2002 Nov 28; 185(2):163-72. PubMed ID: 12169390
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
    Gopal P, Rehman RU, Chadha KS, Qiu M, Colella R.
    Oncol Rep; 2006 Aug 28; 16(2):313-20. PubMed ID: 16820909
    [Abstract] [Full Text] [Related]

  • 5. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
    Cuvier C, Jang A, Hill RP.
    Clin Exp Metastasis; 1997 Jan 28; 15(1):19-25. PubMed ID: 9009102
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
    Navab R, Mort JS, Brodt P.
    Clin Exp Metastasis; 1997 Mar 28; 15(2):121-9. PubMed ID: 9062388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
    Maciewicz RA, Wardale RJ, Etherington DJ, Paraskeva C.
    Int J Cancer; 1989 Mar 15; 43(3):478-86. PubMed ID: 2647640
    [Abstract] [Full Text] [Related]

  • 12. Melanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line.
    Freitas ZF, Rodrigues EG, Oliveira V, Carmona AK, Travassos LR.
    Melanoma Res; 2004 Oct 15; 14(5):333-44. PubMed ID: 15457088
    [Abstract] [Full Text] [Related]

  • 13. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
    Saleh Y, Siewiński M, Kielan W, Ziółkowski P, Gryboś M, Rybka J.
    J Exp Ther Oncol; 2003 Oct 15; 3(6):319-24. PubMed ID: 14678520
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues.
    Kos J, Sekirnik A, Premzl A, Zavasnik Bergant V, Langerholc T, Turk B, Werle B, Golouh R, Repnik U, Jeras M, Turk V.
    Exp Cell Res; 2005 May 15; 306(1):103-13. PubMed ID: 15878337
    [Abstract] [Full Text] [Related]

  • 17. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
    Zajc I, Sever N, Bervar A, Lah TT.
    Cancer Lett; 2002 Dec 10; 187(1-2):185-90. PubMed ID: 12359367
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.